Pancreatic Cancer Action Network Calls for Immediate, Sustained Investment in Research Toward Early Detection and Treatment ...

Because 13% survival is not enough, PanCAN has set a bold goal: Drive the five-year survival rate to 20% by 2030. We will do ...

NEW — Today is One Voice Against Cancer’s Day of Action — Join Us! Today, PanCAN will join other leading patient advocacy organizations across the country for One Voice Against Cancer’s (OVAC) Day of ...

To kick off 2026, PanCAN’s Volunteer Advisory Council shares a warm message of advice and encouragement with PanCAN ...

PanCAN board member Sharon Petry Bittman lost her husband to pancreatic cancer in 2018 and has been committed to raising ...

Thank you for your interest in the Pancreatic Cancer Action Network’s research grants. Check back here for new research grant funding opportunities. This grant is designed to provide bridge funding ...

Patients with pancreatic cancer who participate in clinical research have better outcomes. PanCAN strongly recommends clinical trials at diagnosis and during every treatment decision. Clinical trials ...

Pancreatic cancer begins when abnormal cells in the pancreas grow and divide out of control and form a tumor. The pancreas is a gland located deep in the abdomen, between the stomach and the spine. It ...

Pancreatic cancer remains one of the most challenging cancers to prevent, diagnose or treat. Its risk factors and symptoms are unfamiliar to most. And with no standard test to find pancreatic cancer ...

Staging is the process doctors use to describe the size of the cancer and if it has spread. Knowing the correct stage helps the doctor figure out the prognosis and best treatment plan. After a ...

Pancreatic neuroendocrine tumors (pancreatic NETs or PNETs) account for around 8%* of all pancreatic tumors. They may be benign or malignant and they tend to grow slower than exocrine tumors. They ...

Since 2003, we have awarded 240 grants to 220 scientists at 78 institutions, with a total research investment of approximately $249 million, including the competitive Research Grants Program and ...